Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Kumar

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Immunology|November 13, 2023
Distinct functions and transcriptional signatures in orally induced regulatory T cell populationsMoanaro Biswas, Kaman So, Thais B Bertolini, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2021
Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassetteSandeep R P Kumar, Jun Xie, Shilang Hu, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2020
Engineering and <i>In Vitro</i> Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.
Blood|May 5, 2017
Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8<sup>+</sup> T cellsGeoffrey L Rogers, Jamie L Shirley, Irene Zolotukhin, et al.
The Journal of General Virology|November 20, 2009
Evolution, dispersal and replacement of American genotype dengue type 2 viruses in India (1956-2005): selection pressure and molecular clock analysesSandeep R P Kumar, Jayashri A Patil, D Cecilia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2026
Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transferRebecca Xicluna, Kentaro Yamada, Miguel Gonzalez-Visiedos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2023
TLR9-independent CD8<sup>+</sup> T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signalingSandeep R P Kumar, Moanaro Biswas, Di Cao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A miceJohn S S Butterfield, Kentaro Yamada, Thais B Bertolini, et al.
Nature Communications|November 25, 2021
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine modelsChady H Hakim, Sandeep R P Kumar, Dennis O Pérez-López, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Frontiers in Immunology|November 13, 2023
Distinct functions and transcriptional signatures in orally induced regulatory T cell populationsMoanaro Biswas, Kaman So, Thais B Bertolini, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2021
Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassetteSandeep R P Kumar, Jun Xie, Shilang Hu, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2020
Engineering and <i>In Vitro</i> Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.
Blood|May 5, 2017
Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8<sup>+</sup> T cellsGeoffrey L Rogers, Jamie L Shirley, Irene Zolotukhin, et al.
The Journal of General Virology|November 20, 2009
Evolution, dispersal and replacement of American genotype dengue type 2 viruses in India (1956-2005): selection pressure and molecular clock analysesSandeep R P Kumar, Jayashri A Patil, D Cecilia, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2026
Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transferRebecca Xicluna, Kentaro Yamada, Miguel Gonzalez-Visiedos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2023
TLR9-independent CD8<sup>+</sup> T cell responses in hepatic AAV gene transfer through IL-1R1-MyD88 signalingSandeep R P Kumar, Moanaro Biswas, Di Cao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A miceJohn S S Butterfield, Kentaro Yamada, Thais B Bertolini, et al.
Nature Communications|November 25, 2021
Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine modelsChady H Hakim, Sandeep R P Kumar, Dennis O Pérez-López, et al.
Pageof 6